论文部分内容阅读
OBJECTIVE To evaluate the p73 gene G4C14-to-A4T14 double nucleotide polymorphism with both increased gastric cancer(GC) risk and different histological subtypes of GC in a northwestern Chinese population. METHODS Genotyping of the polymorphism of the p73 gene was conducted with PCR-CTPP. RESULTS All 385 GC patients including 305 diffuse-type and 80 intestinal-type cases and 412 healthy controls were investigated.The frequencies of p73 AT/AT,AT/GC,and GC/GC genotypes were 28.1%,47.1%,and 24.8% in the controls,and were 22.0%,45.0%,and 33.0% in GC cases respectively;the GC/GC homozygote frequency was higher in GC cases,mainly in diffuse type compared to the controls with OR=1.71(1.16～2.51) and 1.87 (95%CI,1.24～2.81) respectively.The results showed that carriers of the p73 G4A GC/GC homozygote had a 1.71-time higher risk of GC,especially of the diffuse-type GC compared to the controls. The carriers of the AT/GC heterozygote also had a slightly increased risk of GC cancer,mainly on intestinal-type GC.This is the first report that the p73 G4A double-nucleotide polymorphism is associated with an increased risk of diffuse-type gastric cancer. CONCLUTION The p73 G4A GC/GC genotype is associated with an increased risk of gastric cancer,especially of the GC diffuse-type.
OBJECTIVE To evaluate the p73 gene G4C14-to-A4T14 double nucleotide polymorphism with both increased gastric cancer (GC) risk and different histological subtypes of GC in a northwestern Chinese population. METHODS Genotyping of the polymorphism of the p73 gene was conducted with PCR-CTPP Results All 385 GC patients including 305 diffuse-type and 80 intestinal-type cases and 412 healthy controls were investigated. These frequencies of p73 AT / AT, AT / GC, and GC / GC genotypes were 28.1%, 47.1%, and 24.8 The GC / GC homozygote frequency was higher in GC cases, the predominantly diffuse type compared to the controls with OR = 1.71 (1.16-2.51) and 1.87 (95% CI, 1.24-2.81) respectively.The results showed that carriers of the p73 G4A GC / GC homozygote had a 1.71-time higher risk of GC, especially for the diffuse-type GC than the controls. The carriers of the AT / GC heterozygote also had a slightly increased risk of GC cancer, mainly on inte stinal-type GC. This is the first report that the p73 G4A double-nucleotide polymorphism is associated with an increased risk of diffuse-type gastric cancer. CONCLUTION The p73 G4A GC / GC genotype is associated with an increased risk of gastric cancer, especially of the GC diffuse-type.